Houdebine, Journal of Biotechnology, vol. 34, pp. 269-287,1994. |
Strojek & Wagner, Genetic Engineering: Principles and Methods, vol. 10, pp. 221-246, 1988. |
Wall, Theriogenology, vol. 45, pp. 57-68, 1996. |
Kappel et al., Current Opinion in Biotechnology, vol. 3, pp. 548-533, 1992. |
Hippenmeyer et al., Molecular and Cellular Endocrinology, vol. 107, pp. 155-164, Feb. 1995. |
Shen et al., EMBO Journal, vol. 13, pp. 1375-1385, Mar. 15, 1994. |
Sittler et al., DNA and Cell Biology, vol. 9, pp. 511-518, Sep. 1990. |
Akita et al., Journal of Clinical Investigation, vol. 95, pp. 1288-1298, Mar. 1995. |
Liu et al., Molecular and Cellular Biology, vol. 12, pp. 3978-3990, Sep. 1992. |
Westphal, FASEB Journal, vol. 3, pp. 117-120, 1989. |
Akita, Sadanori, Jonathan Malkin and Shlomo Melmed, "Disrupted Murine Leukemia Inhibitory Factor (LIF) Gene Attenuates Adrenocorticotropic Hormone (ACTH) Secretion," Endocrinology, vol. 137, No. 7, pp. 3140-3143. |
Akita, Sadanori, et al., "Pituitary-directed Leukemia Inhibitory Factor Transgene Forms Rathke's Cleft Cysts and Impairs Adult Pituitary Function-A Model for Human Pituary Rathke's Cysts," The Journal of Clinical Investigation, vol. 99, No. 10, May 1997, pp. 2462-2469. |
Bamber, Bruce A. et al., "Leukemia Inhibitory Factor Induces Nuerotransmitter Switching in Transgenic Mice," Proceedings of the National Academy of Science USA, vol. 91, pp. 7838-7843, Aug. 1994, Neurobiology. |
Shellard, Joan et al., "Role of Leukemia Inhibitory Factor During Mammalian Development," European Cytokine Network, vol. 7 No. 4, Dec. 1996, pp. 699-712. |
Bamber et al. Aug. 1994, Proc. Natl. Acad. Sci. USA, 91:7839-7843. |
Barloon et al., Mar./Apr. 1988, AJNR, 9:406-407. |
Fischer et al., 1990, J. Neurosurg, 73:534-540. |
Stewart et al., Sep. 1992, Nature, 359:76-79. |
Yasargil et al., 1990, J. Neurosurg, 73:3-11. |